Omnicell, Inc.

Omnicell, Inc., a for-profit manufacturer of pharmacy automation and medication management solutions headquartered in Cranberry Township, Pennsylvania, operates exclusively as a prime contractor supplying automated medication dispensing cabinets, point-of-use medication systems, workflow management software, controlled substance management solutions, and comprehensive maintenance and support services to federal healthcare agencies. The vendor competes full-and-open across its federal footprint with no SBA set-aside designations; all recent awards carry no set-aside designation, reflecting Omnicell's established competitive market position and the proprietary, sole-source character of much of its equipment-maintenance work.

Omnicell's customer concentration sits overwhelmingly with the Department of Veterans Affairs and its Veterans Integrated Service Networks. The top five funding customers by combined potential value account for approximately 79 percent of the vendor's total federal pipeline: VISN 12 dominates dollars at $1.2 billion combined potential value across 59 awards (representing a 2023 consolidation of pharmacy automation procurement); VISN 20 follows at $786.1 million across 275 awards; VISN 22 at $618.6 million across 441 awards; VISN 17 at $134.5 million across 221 awards; and VISN 5 at $116.1 million across 138 awards. By award count, VISN 22 and VISN 20 rank in the top five alongside Army Medical Command (307 awards, $48.8 million) and VISN 10 (303 awards, $70.6 million), signaling that while the VA dominates dollars, Army healthcare also places significant order volume. The vendor maintains distinct positioning across the VA system: it holds the $35 million VISN 5 Blanket Purchase Agreement (expiring June 29, 2030), a $3.3 million VISN 5 BPA awarded October 1, 2025, a $19.2 million VISN 20 BPA (originally June 17, 2024, expiring May 31, 2026), a $2.3 million single-award IDIQ for VISN 23 maintenance services (May 1, 2026 through April 30, 2029), and numerous vendor-specific indefinite delivery vehicles across individual VA medical centers. Recent activity through the past five years shows 168–193 awards per year, declining slightly to 154 in both 2024 and 2025, with 60 awards recorded to date in 2026 (a sparse sample as of mid-July).

Omnicell's primary federal vehicle is the GSA Medical Equipment and Supplies Federal Supply Schedule (FSS-65-II-A), under which it holds a position generating the vast majority of its task order activity. The source names 3,112 task orders against the FSS-65-II-A schedule with $2.1 billion in combined potential value, along with Federal Supply Schedule V797P4313A (1,780 task orders, $860.2 million). The vendor also operates under multiple single-award BPAs issued by individual VISNs, eliminating the need for separate competitive procurements for discrete orders. Omnicell does not appear as a subcontractor on any federal awards in the source; the vendor's federal footprint is exclusively prime contracting.

Representative recent work illustrates Omnicell's core federal mission. In June 2025, VISN 5 awarded a $35 million five-year BPA for automated dispensing cabinets, point-of-use medication systems, workflow management, and maintenance across VISN 5's network of VA medical centers. In October 2025, VISN 20 issued a $5.3 million BPA call for point-of-use cabinets and services at Mountain View, California. VISN 22 issued a $4.3 million delivery order in May 2026 for pharmacy maintenance services across multiple facilities. The Indian Health Service procured Omnicell lease buyouts, cabinet maintenance, and medication dispensing systems totaling several hundred thousand dollars across fiscal 2026. The Defense Health Agency awarded point-of-use cabinet upgrades and server maintenance work at Fort Eisenhower ($809,750) and Fort Gordon ($177,052) in 2025–2026. The National Institutes of Health Clinical Center executed multiple delivery orders for onsite support of server upgrades, cabinet installation, and equipment buyouts totaling roughly $1.2 million in aggregate. Omnicell supplies are characterized by firm fixed pricing on both equipment and maintenance; most awards specify no set-aside designation and reflect non-competitive procurement under existing schedule or BPA vehicles.

Omnicell operates with two named subsidiaries: Pandora Data Systems, Inc. and Aesynt Incorporated (a for-profit manufacturer of goods). The vendor's NAICS footprint is dominated by Surgical and Medical Instrument Manufacturing (4,511 awards), with secondary presence in medical equipment repair and maintenance, home health equipment rental, and medical equipment wholesaling. The primary PSC is Medical and Surgical Instruments, Equipment, and Supplies (1,880 awards), followed by maintenance and repair services (1,015 awards), hospital furniture and equipment (659 awards), and medical equipment leasing and rental (418 awards).

Omnicell's 177 awards with ultimate completion dates in the next twenty-four months carry combined potential value of $70.6 million and represent recompete or renewal exposure. The vendor's aggregate federal contract footprint spans 5,195 prime awards totaling $3.62 billion in combined potential value, with $907.1 million obligated (25 percent), across 57 distinct customer agencies. The bulk of revenue derives from the VA system and department-wide federal healthcare entities, where Omnicell has established itself as the primary incumbent vendor for pharmacy automation and medication management infrastructure, leveraging proprietary equipment designs and OEM-exclusive service contracts to sustain its market position across multiple VA regional networks.